Seed VC · UK

Advent Life Sciences

Active

What they invest in

A venture capital firm for visionary innovators focused on building innovative life sciences businesses by turning breakthrough science into approved medicines or medical products, starting and investing in early and mid-stage companies with a first-in-class or best-in-class approach.

Who they back

DeepTechHealthtechBiotechSeries ASeries B+

Business models

biotech_therapeutics, deeptech_ip, platform

Customer segments

Researchers, Enterprise

Geography

UK, Europe, US

Recent investments

  • Aura Biosciences
  • Amphista Therapeutics
  • Levicept

The people who write checks

12 partners on file at Advent Life Sciences, with the firm's email pattern for cold outreach. Score your deck (free, 30 seconds) to unlock direct contact for this firm and 47,000+ others.

We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.

Why this firm matters for fundraising founders

Advent Life Sciences writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks Advent Life Sciences alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.

At a glance

Based in
United Kingdom
Last known deal
Dec 2018
Portfolio last checked
Oct 6, 2026
Website
www.adventls.com ↗

Other firms investing in DeepTech

See all investors

Is Advent Life Sciences the right fit for your deck?

Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Advent Life Sciences is one of them, and we'll tell you exactly where they sit in your top 100.